Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy
David J. Adelstein(Cleveland Clinic), Gregory Zuccaro(Unknown), Jay P. Ciezki(Cleveland Clinic), Marjorie A. Larto(Cleveland Clinic), Lisa Rybicki(Cleveland Clinic Lerner College of Medicine), John A. Dumot(University Hospitals Cleveland Medical Center), Thomas W. Rice(Medical College of Wisconsin), Malcolm M. DeCamp(University of Wisconsin Carbone Cancer Center), Jerrold P. Saxton(Cleveland Clinic), John J. Vargo(Cleveland Clinic)
Cited by 120
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
|Journal of Cardiothoracic and Vascular Anesthesia|1997|1.3k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632